Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California
…, G Masinde, C Chan, AT Yu, SJ Chai, E Villarino… - Science, 2020 - science.org
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has spread globally, with >365,000 cases in California …
syndrome coronavirus 2 (SARS-CoV-2) has spread globally, with >365,000 cases in California …
Evidence for limited early spread of COVID-19 within the United States, January–February 2020
MA Jorden, SL Rudman, E Villarino, S Hoferka… - Morbidity and Mortality …, 2020 - JSTOR
From January 21 through February 23, 2020, public health agencies detected 14 US cases
of coronavirus disease 2019 (COVID-19), all related to travel from China (1, 2). The first …
of coronavirus disease 2019 (COVID-19), all related to travel from China (1, 2). The first …
[HTML][HTML] Evidence for limited early spread of COVID-19 within the United States, January–February 2020
…, MA Jorden, SL Rudman, E Villarino… - … and Mortality Weekly …, 2020 - ncbi.nlm.nih.gov
From January 21 through February 23, 2020, public health agencies detected 14 US cases
of coronavirus disease 2019 (COVID-19), all related to travel from China (1, 2). The first …
of coronavirus disease 2019 (COVID-19), all related to travel from China (1, 2). The first …
Infectious diseases and death among nursing home residents: results of surveillance in 13 nursing homes
C Beck-Sague, E Villarino, D Giuliano… - Infection Control & …, 1994 - cambridge.org
An increasing proportion of the US population resides in nursing homes (NHs). No surveillance
system exists for infections in these facilities. To determine the incidence and types of …
system exists for infections in these facilities. To determine the incidence and types of …
[HTML][HTML] A genomic survey of SARS-CoV-2 reveals multiple introductions into Northern California without a predominant lineage
…, M Park, C Chan, TY Alexander, SJ Chai, E Villarino… - MedRxiv, 2020 - ncbi.nlm.nih.gov
The COVID-19 pandemic caused by the novel coronavirus SARS-CoV-2 has spread
globally, resulting in> 300,000 reported cases worldwide as of March 21st, 2020. Here we …
globally, resulting in> 300,000 reported cases worldwide as of March 21st, 2020. Here we …
Sociodemographic characteristics, comorbidities, and mortality among persons diagnosed with tuberculosis and COVID-19 in close succession in California, 2020
…, AS Chitnis, A Kadakia, E Villarino… - JAMA network …, 2021 - jamanetwork.com
Importance Tuberculosis (TB) and COVID-19 are respiratory diseases that disproportionately
occur among medically underserved populations; little is known about their epidemiologic …
occur among medically underserved populations; little is known about their epidemiologic …
[HTML][HTML] Three months of rifapentine and isoniazid for latent tuberculosis infection
TR Sterling, ME Villarino, AS Borisov… - … England Journal of …, 2011 - Mass Medical Soc
Background Treatment of latent Mycobacterium tuberculosis infection is an essential component
of tuberculosis control and elimination. The current standard regimen of isoniazid for 9 …
of tuberculosis control and elimination. The current standard regimen of isoniazid for 9 …
[HTML][HTML] Postoperative infections traced to contamination of an intravenous anesthetic, propofol
…, LA Bland, MJ Arduino, ME Villarino… - … England Journal of …, 1995 - Mass Medical Soc
Background Between June 1990 and February 1993, the Centers for Disease Control and
Prevention conducted investigations at seven hospitals because of unusual outbreaks of …
Prevention conducted investigations at seven hospitals because of unusual outbreaks of …
Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection
JA Jereb, SV Goldberg, K Powell, ME Villarino… - 2011 - stacks.cdc.gov
Preventing tuberculosis (TB) by treating latent Mycobacterium tuberculosis infection (LTBI) is
a cornerstone of the US strategy for TB elimination (1,2). Three randomized controlled trials …
a cornerstone of the US strategy for TB elimination (1,2). Three randomized controlled trials …
Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and …
ME Villarino, NA Scott, SE Weis, M Weiner… - JAMA …, 2015 - jamanetwork.com
Importance Three months of a once-weekly combination of rifapentine and isoniazid for
treatment of latent tuberculosis infection is safe and effective for persons 12 years or older. …
treatment of latent tuberculosis infection is safe and effective for persons 12 years or older. …